Theravance Biopharma, Inc. · NASDAQ:TBPH
O'Connor Donal received 6,009 Theravance Biopharma, Inc. shares as an award (Form 4)
Traded Jun 12, 2026 · Filed Jun 16, 2026
On Jun 12, 2026, O'Connor Donal (Director) received 6,009 Theravance Biopharma, Inc. shares as an award, leaving 80,213 shares. Filed Jun 16, 2026 (Form 4).
- Awarded
- 6,009 shares
- Holding after
- 80,213 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 12, 2026 | Ordinary Shares | Award | 6,009 | 80,213 | Direct |
Source
Related
- Theravance Biopharma, Inc.
- O'Connor Donal
- Theravance Biopharma, Inc. shareholders
- Form 4 · O'Connor Donal · Sep 24, 2026
- Form 4 · Weiss Asset Management LP · Sep 28, 2026
- Schedule 13D/A · Weiss Asset Management LP · Sep 25, 2026
- Form 4 · Pakianathan Deepika · Sep 24, 2026
- Form 4 · Mitchell Dean J · Sep 24, 2026
- Form 4 · Gray Susannah · Sep 24, 2026